Alphatec Holdings, Inc. (ATEC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

K. Gong
JPMorgan Chase & Co, Research Division

Thanks, everyone, for joining today. My name is Allen Gong. I’m here on the medical supplies and devices team at JPMorgan. It’s my pleasure to introduce the management team of Alphatec for prepared remarks. We’ll be starting off with Pat Miles, and then Todd will be joining us for the Q&A. But yes, Pat, do you want to start us off?

Patrick Miles
Executive Chairman, CEO & President

Hello. My name is Pat Miles. I am the Chairman and CEO of Alphatec Spine. Would love to talk to you today a little bit about delivering long-term differentiated growth. And so it’s kind of our story. You will get some forward-looking statements. So read that at your leisure.

Really kind of 3 things we’d love to discuss today is really a little bit about the track record of execution. It’s been very strong. I want to go into a little bit about. There’s still a ton of growth opportunity within this space and within what we’re building as well as talk a little bit about the foundation from which we’re building from an infrastructure perspective. And then as stated, Todd and I will happily take questions, and we’ll try to spend the majority of time on that.

I would tell you, I’ve been at this at Alphatec for 8 years, and I think there’s been great consistency in terms of what the reflected track record is. I think that this is a great time to be in spine. I think that